Lindbrook Capital’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,500
| Closed | -$8.1K | – | 2893 |
|
|
2024
Q3 | $8.1K | Hold |
2,500
| – | – | ﹤0.01% | 1792 |
|
|
2024
Q2 | $7.5K | Hold |
2,500
| – | – | ﹤0.01% | 1790 |
|
|
2024
Q1 | $11.6K | Hold |
2,500
| – | – | ﹤0.01% | 1489 |
|
|
2023
Q4 | $10.4K | Hold |
2,500
| – | – | ﹤0.01% | 1532 |
|
|
2023
Q3 | $7.5K | Hold |
2,500
| – | – | ﹤0.01% | 1556 |
|
|
2023
Q2 | $6.15K | Hold |
2,500
| – | – | ﹤0.01% | 1703 |
|
|
2023
Q1 | $5.65K | Hold |
2,500
| – | – | ﹤0.01% | 1801 |
|
|
2022
Q4 | $8.73K | Sell |
2,500
-96
| -4% | -$335 | ﹤0.01% | 1504 |
|
|
2022
Q3 | $96K | Buy |
2,596
+73
| +3% | +$2.7K | 0.02% | 444 |
|
|
2022
Q2 | $48K | Buy |
2,523
+23
| +0.9% | +$438 | 0.01% | 671 |
|
|
2022
Q1 | $67K | Hold |
2,500
| – | – | 0.01% | 592 |
|
|
2021
Q4 | $56K | Buy |
+2,500
| New | +$56K | 0.01% | 678 |
|